Clinical TrialsSearch results
Number of results: 1191
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
- Advanced Cholangiocarcinoma Harboring FGFR2 Gene Fusion or Rearrangements
- Elsayed Hamdy
- 2023-04-21
Other
- Multicenter Phase II study of modified FOLFOX7(combination chemotherapy of infusional 5-FU/l-Leucovorin and intermittent Oxaliplatin)with bevacizumab in the first-line therapy of colorectal cancer - CRAFT trial-
- advanced colorectal cancer
- Epidemiological and Clinical Research Information Network (ECRIN)
- 2009-09-01
Other
- A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil; OK-432 and Montanide; ISA-51 in patients with cancers expressing NY-ESO-1 antigen
- advanced esophageal cancer, stomach cancer, non-small cell lung cancer (NSCLC), malignant melanoma
- Department of Immunology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2008-07-24
Other
- A phase I study of cancer vaccine with NY-ESO-1 overlapping peptides in patients with advanced cancers expressing NY-ESO-1 antigen
- advanced esophageal cancer, stomach cancer, non-small cell lung cancer (NSCLC), malignant melanoma, bladder cancer.
- Department of Immunology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2009-04-10
No Longer Recruiting
- A phase I study of TS-1 and docetaxel for advanced gastric cancer
- advanced gastric cancer
- Department of Medical Oncology, Kinki University School of Medicine
- 2005-09-12
Other
- A phase II study of combination Docetaxel, Cisplatin, and S-1 as neoadjuvant chemotherapy for advanced gastric cancer.
- advanced gastric cancer
- Dept. of Internal Medicine(4)
- 2007-08-15
Other
- A phase II study to confirm the feasibility of S-1 plus CPT-11 as a post operative chemotherapy for the patients with advanced gastric cancer in stage IIIA and IIIB (OGSG 0801)
- advanced gastric cancer
- Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)
- 2009-07-10
Other
- Neoadjuvant chemotherapy using the TXL and CDDP followed by surgery for advanced gastric cancer - Phase II
- advanced gastric cancer
- TC therapy for gastric cancer study group
- 2005-11-09
Other
- OGSG 1701
- advanced gastric cancer with lymph node metastases cannot be resected curatively, or poor prognosis.
- SUGIMOTO Naotoshi
- 2019-03-26
Other
- A phase 1 study of the combination chemotherapy of sorafenib with cisplatin transcatheter arterial infusion for advanced hepatocellular carcinoma.
- advanced hepatocellular carcinoma
- National Cancer Center Hospital
- 2008-12-02